CPAY vs TECH · P/E 21, rev $3.97B vs P/E 65, rev $1.22B
Corpay Inc (CPAY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Corpay Inc (CPAY) is a software - infrastructure company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CPAY revenue for 2024-12-31 was $3.97B. Net income was $1.00B. Revenue was up 5.8% from 2023-12-31 to 2024-12-31. CPAY currently screens at market cap $23.09B and trailing P/E 21.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CPAY currently screens at market cap $23.09B and trailing P/E 21.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CPAY and TECH stock pages for the full models.
Not investment advice.